Log in   

Login to your account

Ocular Drug Delivery Group

Ocular drug delivery is a limiting factor in the development of new medications to the treat diseases of the posterior eye segment. Research on delivery systems, test models and computational models opens avenues for improved ocular drug treatments. Our group has more than 20 years of experience in ocular drug delivery including: cell model development, drug discovery, drug formulation, kinetic modeling, and basic cell research of the eye. The research group is multidisciplinary including expertise in pharmaceutical sciences, molecular and cell biology, materials science, bio-organic chemistry, physical chemistry, and molecular modeling.



Arto Urtti, Ph.D, Group Leader

Professor Urtti has led the Centre for Drug Research (CDR) at the University of Helsinki since 2005. Professor Urtti’s has authored more than 220 peer-reviewed articles and 20 patents and patent applications.

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

From the Director

You must have the Adobe Flash Player installed to view this player.

Recent Activities